Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2008

01.11.2008 | Gastrointestinal Oncology

Preoperative Resolution of Jaundice Following Biliary Stenting Predicts More Favourable Early Survival in Resected Pancreatic Ductal Adenocarcinoma

verfasst von: Richard A. Smith, MRCS, K. Dajani, MRCS, S. Dodd, MSc, P. Whelan, BSc, M. Raraty, FRCS, R. Sutton, FRCS, F. Campbell, FRCPath, J. P. Neoptolemos, FRCS, P. Ghaneh, FRCS

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Despite the widespread use of endoscopic biliary stenting in patients presenting with potentially resectable pancreatic cancer, there is no general consensus regarding whether this represents a superior management approach over expeditious surgical intervention. The objective of this study was to investigate the influence of preoperative biliary stenting and resolution of jaundice on subsequent postoperative survival following resection for pancreatic cancer.

Methods

155 patients undergoing partial pancreatoduodenectomy for pancreatic ductal adenocarcinoma between January 1997 and August 2007 were identified from a prospectively maintained database.

Results

There was no survival difference when comparing patients undergoing preoperative biliary drainage (n = 130) with those who did not (n = 25) (log rank, P = 0.981). When analysing individual prognostic factors as continuous variables in univariate Cox analysis, lower albumin levels (P = 0.016), elevated alkaline phosphatase levels (P = 0.011) and elevated CRP levels (P = 0.021) were associated with poorer overall survival. Multivariable Cox regression demonstrated that both albumin (P = 0.008) and CRP (P = 0.038) remained significant independent predictors of overall survival alongside lymph node ratio (P = 0.018). Although preoperative bilirubin levels were not associated with overall survival when analysed as a continuous variable (Cox, P = 0.786), the presence of jaundice (i.e., bilirubin >35 μmol/l) at the time of surgery was a significant adverse predictor of early survival in patients undergoing preoperative biliary drainage (Breslow–Gehan–Wilcoxon, P = 0.013) and remained a significant predictor of early survival when included in a further Cox analysis with censoring of cases who survived beyond 6 months (Cox, P = 0.017).

Conclusion

These results suggest that the presence of jaundice at the time of resection has an adverse impact on early, but not overall, postoperative survival in pancreatic cancer patients undergoing preoperative biliary drainage.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43–66PubMedCrossRef Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43–66PubMedCrossRef
3.
Zurück zum Zitat Alexakis N, Halloran C, Raraty M, et al. Current standards of surgery for pancreatic cancer. Br J Surg 2004; 91:1410–27PubMedCrossRef Alexakis N, Halloran C, Raraty M, et al. Current standards of surgery for pancreatic cancer. Br J Surg 2004; 91:1410–27PubMedCrossRef
4.
Zurück zum Zitat Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935; 102:763–79PubMedCrossRef Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935; 102:763–79PubMedCrossRef
5.
Zurück zum Zitat Sewnath ME, Karsten TM, Prins MH, et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236:17–27PubMedCrossRef Sewnath ME, Karsten TM, Prins MH, et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236:17–27PubMedCrossRef
6.
Zurück zum Zitat Povoski SP, Karpeh MS, Conlon KC, et al. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 1999; 2:131–42CrossRef Povoski SP, Karpeh MS, Conlon KC, et al. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 1999; 2:131–42CrossRef
7.
Zurück zum Zitat Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative biliary decompression on pancreatiocduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 2001; 234:47–55PubMedCrossRef Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative biliary decompression on pancreatiocduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 2001; 234:47–55PubMedCrossRef
8.
Zurück zum Zitat Sewnath ME, Birjmohun RS, Rauws EAJ, et al. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 2001;192:726–34PubMedCrossRef Sewnath ME, Birjmohun RS, Rauws EAJ, et al. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 2001;192:726–34PubMedCrossRef
9.
Zurück zum Zitat Campbell F, Bennett M, Foulis AJ. Minimum Dataset for Histopathological Reporting of Pancreatic, Ampulla of Vater and Bile Duct Carcinoma. Royal College of Pathologists; 2002. http://www.rcpath.org Campbell F, Bennett M, Foulis AJ. Minimum Dataset for Histopathological Reporting of Pancreatic, Ampulla of Vater and Bile Duct Carcinoma. Royal College of Pathologists; 2002. http://​www.​rcpath.​org
10.
Zurück zum Zitat Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141:610–8PubMedCrossRef Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141:610–8PubMedCrossRef
11.
Zurück zum Zitat Gehan EA. A generalised Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrica 1965; 52:203–23 Gehan EA. A generalised Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrica 1965; 52:203–23
12.
Zurück zum Zitat Altman DG, Lausen B, Sauerbrei W, et al. Dangers of using optimal cutpoints in the evaluation of prognostic factors. J Nat Cancer Inst 1994; 86:829–35PubMedCrossRef Altman DG, Lausen B, Sauerbrei W, et al. Dangers of using optimal cutpoints in the evaluation of prognostic factors. J Nat Cancer Inst 1994; 86:829–35PubMedCrossRef
13.
Zurück zum Zitat Hatfield AR, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 1982; 2:896–9PubMedCrossRef Hatfield AR, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 1982; 2:896–9PubMedCrossRef
14.
Zurück zum Zitat McPherson GA, Benjamin IS, Hodgson HJ, et al. Preoperative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 1984; 71:371–5PubMedCrossRef McPherson GA, Benjamin IS, Hodgson HJ, et al. Preoperative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 1984; 71:371–5PubMedCrossRef
15.
Zurück zum Zitat Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous drainage reduce operative risk or increase hospital cost? Ann Surg 1985; 201:545–53PubMedCrossRef Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous drainage reduce operative risk or increase hospital cost? Ann Surg 1985; 201:545–53PubMedCrossRef
16.
Zurück zum Zitat Smith RC, Pooley M, George CR, et al. Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized, controlled trial examining renal function. Surgery 1985; 97:641–8PubMed Smith RC, Pooley M, George CR, et al. Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized, controlled trial examining renal function. Surgery 1985; 97:641–8PubMed
17.
Zurück zum Zitat Lai EC, Mok FP, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994;81:1195–8PubMedCrossRef Lai EC, Mok FP, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994;81:1195–8PubMedCrossRef
18.
Zurück zum Zitat Tsao RE, Almhanna K, Lazaryan A, et al. Is adjuvant radiation plus chemotherapy for resectable pancreatic adenocarcinoma associated with improved survival? The Cleveland Clinic experience. ASCO 2008. Abstract No. 201 Tsao RE, Almhanna K, Lazaryan A, et al. Is adjuvant radiation plus chemotherapy for resectable pancreatic adenocarcinoma associated with improved survival? The Cleveland Clinic experience. ASCO 2008. Abstract No. 201
19.
Zurück zum Zitat Leung K, Elashoff RM, Abdelmonem AA. Censoring issues in survival analysis. Annu Rev Public Health 1997; 18:83–104PubMedCrossRef Leung K, Elashoff RM, Abdelmonem AA. Censoring issues in survival analysis. Annu Rev Public Health 1997; 18:83–104PubMedCrossRef
20.
Zurück zum Zitat Jagannath P, Dhir V, Shrikhande S, et al. Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy. Br J Surg 2005; 92:356–61PubMedCrossRef Jagannath P, Dhir V, Shrikhande S, et al. Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy. Br J Surg 2005; 92:356–61PubMedCrossRef
21.
Zurück zum Zitat Jethwa P, Breuning E, Bhati C, et al. The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery. Aliment Pharmacol Ther 2007; 25:1175–80PubMedCrossRef Jethwa P, Breuning E, Bhati C, et al. The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery. Aliment Pharmacol Ther 2007; 25:1175–80PubMedCrossRef
22.
Zurück zum Zitat Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001; 182:197–201PubMedCrossRef Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001; 182:197–201PubMedCrossRef
23.
Zurück zum Zitat Hashimoto K, Ikeda Y, Korenaga D, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005; 103:1856–64PubMedCrossRef Hashimoto K, Ikeda Y, Korenaga D, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005; 103:1856–64PubMedCrossRef
24.
Zurück zum Zitat Crozier JE, McKee RF, McArdle CS, et al. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg 2007; 94:1028–32PubMedCrossRef Crozier JE, McKee RF, McArdle CS, et al. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg 2007; 94:1028–32PubMedCrossRef
25.
Zurück zum Zitat Jamieson NB, Glen P, McMillan DC, et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 2005; 17:21–3CrossRef Jamieson NB, Glen P, McMillan DC, et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 2005; 17:21–3CrossRef
26.
Zurück zum Zitat Glen P, Jamieson NB, McMillan DC, et al. Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 2006; 6:450–3PubMedCrossRef Glen P, Jamieson NB, McMillan DC, et al. Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 2006; 6:450–3PubMedCrossRef
27.
Zurück zum Zitat Winter JM, Cameron JL, Yeo CJ, et al. Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 2007; 204:1029–36PubMedCrossRef Winter JM, Cameron JL, Yeo CJ, et al. Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 2007; 204:1029–36PubMedCrossRef
28.
Zurück zum Zitat Giger U, BüchlerM, Farhadi J, et al. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol 2007; 14:2798–806PubMedCrossRef Giger U, BüchlerM, Farhadi J, et al. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol 2007; 14:2798–806PubMedCrossRef
29.
Zurück zum Zitat van der Gaag NA, de Castro SM, Rauws EA, et al. Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; Drainage vs (direct) Operation (DROP-trial). BMC Surg 2007; 7:3PubMedCrossRef van der Gaag NA, de Castro SM, Rauws EA, et al. Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; Drainage vs (direct) Operation (DROP-trial). BMC Surg 2007; 7:3PubMedCrossRef
Metadaten
Titel
Preoperative Resolution of Jaundice Following Biliary Stenting Predicts More Favourable Early Survival in Resected Pancreatic Ductal Adenocarcinoma
verfasst von
Richard A. Smith, MRCS
K. Dajani, MRCS
S. Dodd, MSc
P. Whelan, BSc
M. Raraty, FRCS
R. Sutton, FRCS
F. Campbell, FRCPath
J. P. Neoptolemos, FRCS
P. Ghaneh, FRCS
Publikationsdatum
01.11.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0148-z

Weitere Artikel der Ausgabe 11/2008

Annals of Surgical Oncology 11/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.